Trade Mark Journal No.2025/038 19 September 2025
WO0000001872925 (42)
Office of origin: United States of America
Date of International Registration:20 June 2025
Date of designation in the UK:
20 June 2025
The mark consists of stacked terms "TRIAL COMPLEXITY", "OPTIMIZER" and "BY BCG X", all to the left, and partially overlapping, a slash design.
Registration of this mark shall give no right to the exclusive use of TRIAL COMPLEXITY OPTIMIZER.
International priority date claimed: 20 December 2024
(United States of America)
(98914384)
- Class 42
- Providing temporary use of online non-downloadable software for business process management; providing temporary use of online non-downloadable generative AI software to assist businesses with clinical trial design, execution, evaluation, and drafting or related reports; providing temporary use of online non-downloadable software to automate document writing for the design, execution, and evaluation of clinical trials; providing temporary use of online non-downloadable software for business management and optimization purposes using technical data, data modelling, AI modelling, and algorithmic processes; providing technical consulting services to businesses in the field of clinical trial optimization, maximizing cost efficiency, and improving success rates; providing scientific and technological consulting services for others with regard to the design, planning, management, and optimization of scientific research and clinical trials.
The Boston Consulting Group, Inc.
Representative: Michael Geller DLA Piper LLP (US), 444 West Lake Street,, Suite 900, Chicago IL 60606, UNITED STATES OF AMERICA